{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:38:09Z","timestamp":1780342689744,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.juro.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T05:51:00Z","timestamp":1368165060000},"page":"1791-1797","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacokinetics of Intravesical Versus Oral Oxybutynin in Healthy Adults: Results of an Open Label, Randomized, Prospective Clinical Study"],"prefix":"10.1097","volume":"190","author":[{"given":"Petra","family":"Krause","sequence":"first","affiliation":[{"name":"Itecra GmbH, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Fuhr","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Clinical Pharmacology Unit, University Hospital, University of Cologne, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schnitker","sequence":"additional","affiliation":[{"name":"Institute of Applied Statistics, Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Mediconomics GmbH, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Stein","sequence":"additional","affiliation":[{"name":"Division of Pediatric Urology, Department of Urology, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rubenwolf","sequence":"additional","affiliation":[{"name":"Division of Pediatric Urology, Department of Urology, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.05.011_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.ju.0000147813.28822.d2","article-title":"Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction","volume":"173","author":"Franco","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF00558247","article-title":"The pharmacokinetics of oxybutynin in man","volume":"35","author":"Douchamps","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.juro.2013.05.011_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14656566.3.4.443","article-title":"Oxybutynin chloride: alterations in drug delivery and improved therapeutic index","volume":"3","author":"Dmochowski","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.juro.2013.05.011_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1248\/bpb.30.955","article-title":"Pharmacokinetics\/pharmacodynamics analysis of the relationship between the in\u00a0vivo micturition pressure and receptor occupancy of (R)-oxybutynin and its metabolite in rats","volume":"30","author":"Mizushima","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.juro.2013.05.011_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin. A\u00a0review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1016\/j.juro.2013.05.011_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/00498259209053145","article-title":"Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers","volume":"22","author":"Hughes","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1016\/j.juro.2013.05.011_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/009127009903900313","article-title":"Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin","volume":"39","author":"Gupta","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.juro.2013.05.011_bib8","first-page":"19","article-title":"Oxybutynin: an overview of the available formulations","volume":"2","author":"McCrery","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.juro.2013.05.011_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1010956832113","article-title":"Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers","volume":"18","author":"Zobrist","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.juro.2013.05.011_bib10","first-page":"562","article-title":"Enantiomers of oxybutynin: in\u00a0vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in\u00a0vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs","volume":"256","author":"Noronha-Blob","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.juro.2013.05.011_bib11","first-page":"867","article-title":"R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine","volume":"247","author":"Kachur","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.juro.2013.05.011_bib12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-5347(01)62703-4","article-title":"Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000019701","article-title":"Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children","volume":"34","author":"Amark","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-5347(17)37845-X","article-title":"The use of intravesical oxybutynin chloride in children with neurogenic bladder","volume":"146","author":"Greenfield","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)36663-6","article-title":"The pharmacokinetics of intravesical and oral oxybutynin chloride","volume":"148","author":"Massad","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0090-4295(93)90098-U","article-title":"Intravesical oxybutynin chloride: experience with 42 patients","volume":"41","author":"Weese","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.05.011_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/003655902317259319","article-title":"Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity","volume":"36","author":"Lehtoranta","year":"2002","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.juro.2013.05.011_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1464-410X.1998.00888.x","article-title":"Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder","volume":"82","author":"Amark","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000475078","article-title":"Intravesical application of oxybutynine: mode of action in controlling detrusor hyperreflexia. Preliminary results","volume":"28","author":"Madersbacher","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1520-6777(2000)19:6<683::AID-NAU6>3.0.CO;2-R","article-title":"Treatment of overactive bladder with modified intravesical oxybutynin chloride","volume":"19","author":"Saito","year":"2000","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2013.05.011_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0022-5347(01)62828-3","article-title":"Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.011_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.1990.tb02523.x","article-title":"The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study","volume":"97","author":"Tapp","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.juro.2013.05.011_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/nau.1930140111","article-title":"Intravesical oxybutynin in patients with posterior rhizotomies and sacral\u00a0anterior root stimulators","volume":"14","author":"Singh","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2013.05.011_bib24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.juro.2008.05.056","article-title":"Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review","volume":"180","author":"Guerra","year":"2008","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713043462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713043462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.05.011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:59:43Z","timestamp":1688216383000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.05.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1016\/j.juro.2013.05.011"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.05.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718016139.793479239","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718016139.793478640","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}